Magnesium Sulfuricum Bbp

Magnesium sulfate, the active ingredient in Magnesium Sulfuricum Bbp, is an electrolyte supplement presented as a sterile solution for intramuscular, intravenous, and subcutaneous use. It is employed to correct magnesium deficiency and to manage conditions such as pre‑eclampsia, torsades de pointes, and severe asthma exacerbations in hospitalized patients.

GNH USA supplies Magnesium Sulfuricum Bbp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnesium Sulfate is used in several clinical situations where magnesium homeostasis is critical.

- Magnesium deficiency: restores normal serum magnesium concentrations and alleviates related neuromuscular symptoms. - Pre‑eclampsia/eclampsia: prevents seizures by counteracting calcium‑mediated excitability in the central nervous system. - Torsades de pointes: stabilises cardiac repolarisation and reduces the risk of ventricular arrhythmias. - Severe asthma exacerbations: relaxes bronchial smooth muscle, improving airflow in acute attacks.

Magnesium Sulfate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Flushing or warmth at the injection site. - Nausea or vomiting. - Headache. - Hypotension due to vasodilation. - Transient facial flushing. - Mild muscle weakness.

Serious or Rare Side Effects: - Respiratory depression or arrest, especially with rapid IV administration. - Cardiac arrest or severe bradycardia. - Hypermagnesemia leading to loss of deep tendon reflexes. - Severe hypotension unresponsive to fluids. - Allergic reactions including anaphylaxis. - Local tissue necrosis if extravasation occurs.

Magnesium Sulfate should be administered with careful clinical monitoring.

- Renal impairment: monitor serum magnesium and adjust dosing. - Cardiac disease: observe ECG for prolonged QT or bradyarrhythmias. - Neuromuscular disorders: avoid high doses in patients with myasthenia gravis. - Concomitant calcium therapy: separate administration times to prevent precipitation. - Pregnancy: use only when clearly needed, as benefits must outweigh potential risks. - Store below 25°C: keep in original container, protect from moisture and light.

Magnesium Sulfate can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Calcium‑containing IV solutions: risk of precipitation and reduced magnesium availability. - Potent neuromuscular blocking agents (e.g., succinylcholine, non‑depolarizing blockers): may cause prolonged paralysis. - Certain antibiotics (e.g., tetracyclines, quinolones): reduced absorption when given orally.

Moderate Interactions (Monitor Closely): - Loop diuretics: increase renal magnesium loss, requiring closer monitoring. - ACE inhibitors or ARBs: additive hypotensive effect. - Digoxin: heightened risk of arrhythmias with concurrent hypermagnesemia. - Other QT‑prolonging drugs: monitor cardiac rhythm for additive effects.